https://openbell.ai/ 2026-11-03T10:47:14.099Z hourly 1.0 https://openbell.ai/support 2026-11-03T10:47:14.099Z monthly 0.7 https://openbell.ai/privacy 2026-11-03T10:47:14.099Z monthly 0.5 https://openbell.ai/terms 2026-11-03T10:47:14.099Z monthly 0.5 https://openbell.ai/feed.json 2026-11-03T10:47:14.099Z hourly 0.8 https://openbell.ai/news/GRAB:1793700100000 2026-11-03T10:01:40.000Z daily 0.9 https://cdn.brandfetch.io/GRAB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Grab Holdings Lifts Annual Revenue Forecast Grab Holdings raised its 2026 annual revenue forecast, citing strong performance and sustained demand in its ride-hailing and food delivery businesses across Southeast Asia. Its shares rose following the announcement. The article did not provide specific revenue figures or the size of the forecast increase. https://openbell.ai/news/ABF:1793698319000 2026-11-03T09:31:59.000Z daily 0.9 https://cdn.brandfetch.io/ABF/w/400/h/400?c=1idopYfmtR7ZKg8QMud Associated British Foods Reports 2025/26 Financial Results and Restructuring Plans Associated British Foods reported 2025/26 revenue of £19.6bn, down 1%, and adjusted operating profit of £1.51bn, down 14%; it forecast further declines in profit and EPS in 2026/27, citing sugar-business challenges and weaker US demand. The company will stop beet processing at its Cantley site in 2027, reducing its UK sugar facilities from four to three and incurring £80m in impairment and restructuring charges. Its planned separation of Primark from its food businesses remains on track for completion in December 2027. ABF proposed a final dividend of 42.3p, keeping the annual dividend at 63.0p per share, and completed £253m in share buybacks. https://openbell.ai/news/SBIN:1793698302000 2026-11-03T09:31:42.000Z daily 0.9 https://cdn.brandfetch.io/SBIN/w/400/h/400?c=1idopYfmtR7ZKg8QMud State Bank of India Reports September Quarter Financial Results State Bank of India reported net profit of Rs 23,038 crore for the quarter ended September 2026, up 14.3% from Rs 20,160 crore a year earlier. Net interest income rose 14.7% year-on-year to Rs 49,142 crore. The bank’s GNPA ratio was 1.39% and NNPA ratio was 0.36%, while provisions for the second quarter totaled Rs 49.16 billion. https://openbell.ai/news/MLEC:1793696566000 2026-11-03T09:02:46.000Z daily 0.9 https://cdn.brandfetch.io/MLEC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Moolec Science SA in Voluntary Liquidation Announces Receipt of Nasdaq Delisting Determination Moolec Science SA, which is in voluntary liquidation, said it received a Nasdaq Staff Delisting Determination dated October 27, 2026. Shareholders approved the company’s winding-up and appointed Joint Voluntary Liquidators on October 20, with 98.4% of votes in favor. Nasdaq cited the liquidation and related public-interest considerations; trading in Moolec’s ordinary shares is scheduled to be suspended at the start of business on November 3, followed by a Form 25-NSE filing to complete the delisting. https://openbell.ai/news/TLSA:1793696560000 2026-11-03T09:02:40.000Z daily 0.9 https://cdn.brandfetch.io/TLSA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Tiziana Life Sciences Announces Positive Topline Data from Phase 2a INFORM-MS Trial Tiziana Life Sciences reported positive topline results from its Phase 2a INFORM-MS trial of intranasal foralumab in patients with non-active secondary progressive multiple sclerosis. The trial met its dual primary endpoints, with the 50 μg dose producing a statistically significant reduction in microglial activation on TSPO PET imaging versus placebo and showing a favorable safety and tolerability profile. The 100 μg dose was also well tolerated but did not achieve a statistically significant reduction in neuroinflammation; the report did not provide financial results or a stock-price impact. https://openbell.ai/news/VIVO:1793696546000 2026-11-03T09:02:26.000Z daily 0.9 https://cdn.brandfetch.io/VIVO/w/400/h/400?c=1idopYfmtR7ZKg8QMud VivoPower PLC Reports FY26 Financial Results VivoPower PLC reported FY26 revenue of $2.545 million, attributed to its Mo i Rana acquisition, while total losses widened to $49.732 million, driven by non-cash charges and transaction costs. The company said AI conversion is its primary strategic focus and identified tenant execution, liquidity, and funding collection as key operational risks. https://openbell.ai/news/LIKE:1793696537000 2026-11-03T09:02:17.000Z daily 0.9 https://cdn.brandfetch.io/LIKE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Likewise Group PLC Trading Update: Revenue Growth and FY26 Profit Forecast Likewise Group reported October revenue growth of 36.7%, with year-to-date revenue up 22.8% year over year, and forecast FY26 profit before tax of at least £6.0 million. The company completed the acquisition and integration of Headlam assets and bought a 90,000-square-foot freehold property in Thatcham, which began receiving deliveries on 22 October. It is adding 16 trucks to its delivery fleet, bringing the total to 192, and expects Concept Flooring Supplies and Crucial Trading to enhance earnings in FY27. https://openbell.ai/news/ISLAX:1793696532000 2026-11-03T09:02:12.000Z daily 0.9 https://cdn.brandfetch.io/ISLAX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Icelandic Salmon Reports Q3 2026 Financial Results Icelandic Salmon reported a Q3 2026 harvest of 5,200 tonnes and positive operational EBIT of EUR 1.4 million. It attributed the results to improved biological conditions, lower production costs and stronger price achievement. Biological challenges in Q4 led the company to shift 1,300 tonnes of planned harvest into 2027. https://openbell.ai/news/KIE:1793696528000 2026-11-03T09:02:08.000Z daily 0.9 https://cdn.brandfetch.io/KIE/w/400/h/400?c=1idopYfmtR7ZKg8QMud KierBAM joint venture secures £600m Devonport defence contract Kier and BAM’s joint venture has secured a £600 million contract to upgrade 10 Dock at Devonport Royal Dockyard in Plymouth. The project, part of Babcock’s Major Nuclear Capital Programme, will improve maintenance capacity and availability for current and future submarine fleets at a facility critical to the UK’s Defence Nuclear Enterprise. The article reports no financial results or share-price impact. https://openbell.ai/news/TRU:1793696525000 2026-11-03T09:02:05.000Z daily 0.9 https://cdn.brandfetch.io/TRU/w/400/h/400?c=1idopYfmtR7ZKg8QMud TruFin Announces Further £17.5m Special Dividend and Head Office Restructuring TruFin announced a further £17.5 million special dividend, equal to 32.48 pence per share, following a £22.5 million special dividend announced in July 2026. The latest payment brings capital returned to shareholders to more than £110 million over 19 months. TruFin is also restructuring its head office, targeting an approximately 30% reduction in annualised costs; after these measures and Oxygen Finance’s acquisition of Rockford Associates, it expects to hold at least £3 million in cash at 31 December 2026. https://openbell.ai/news/FGP:1793696520000 2026-11-03T09:02:00.000Z daily 0.9 https://cdn.brandfetch.io/FGP/w/400/h/400?c=1idopYfmtR7ZKg8QMud FirstGroup Announces Asset Sale and Franchise Contract Awards in West Yorkshire FirstGroup agreed to sell five freehold depots and 330 buses to the West Yorkshire Combined Authority for £109 million; the depot sales are complete, while the buses will transfer as franchise tranches begin in May 2027, January 2028 and October 2028. The company expects an approximately £30 million post-tax disposal gain and about £55 million in cash inflow in FY2027, with further positive impacts in later years. FirstGroup also won two franchise contracts expected to generate around £40 million in combined annual revenue from May 2027. https://openbell.ai/news/ACG:1793696506000 2026-11-03T09:01:46.000Z daily 0.9 https://cdn.brandfetch.io/ACG/w/400/h/400?c=1idopYfmtR7ZKg8QMud ACG Metals to Acquire Blue Moon Norway for US$220 Million ACG Metals has signed a definitive agreement to acquire 100% of Blue Moon Norway AS from Blue Moon Metals Inc. for US$220 million, payable in ACG Class A Ordinary Shares. The assets include the construction-stage Nussir copper mine and exploration-stage NSG property. ACG says the acquisition supports its strategy to become a high-growth European copper producer; the deal is subject to customary closing conditions and approvals, with completion anticipated by November 30, 2026. https://openbell.ai/news/RBI:1793694730000 2026-11-03T08:32:10.000Z daily 0.9 https://cdn.brandfetch.io/RBI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Raiffeisen Bank International Reports Nine-Month Profit Growth and Acquisition Completion Raiffeisen Bank International reported a 10% increase in profit for the first nine months of the year, to €1.1 billion. The bank also confirmed it completed its acquisition of Romania’s Garanti Bank. The company disclosed both developments on November 3, 2026. https://openbell.ai/news/LHA:1793694718000 2026-11-03T08:31:58.000Z daily 0.9 https://cdn.brandfetch.io/LHA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Lufthansa Reports Q3 2026 Results and Lowers Full-Year Operating Profit Outlook Deutsche Lufthansa reported third-quarter 2026 adjusted EBIT of €1.41 billion, up 6% year over year and above analysts’ €1.37 billion estimate. Revenue increased 9% to €12.24 billion, and net profit rose 30% to €1.26 billion, supported by cargo and maintenance demand and cost discipline. The airline lowered its full-year adjusted EBIT outlook to €1.7 billion–€2.0 billion from a previous upper limit of €2.2 billion, citing higher fuel costs and the late stage of the fiscal year; it said the revised range is in line with market expectations. https://openbell.ai/news/EVK:1793694716000 2026-11-03T08:31:56.000Z daily 0.9 https://cdn.brandfetch.io/EVK/w/400/h/400?c=1idopYfmtR7ZKg8QMud Evonik Reports Q3 2026 Results and Increases Full-Year Outlook Evonik Industries reported Q3 2026 adjusted EBITDA of €629 million, up 40% from €509 million a year earlier, supported by higher prices and sales volumes. It posted a net loss of €53 million, mainly due to a €313 million provision for additional efficiency-program measures. Management reaffirmed Evonik’s independence and rejected potential takeover interest from BASF, saying restructuring is expected to make its portfolio more attractive. https://openbell.ai/news/FMS:1793694705000 2026-11-03T08:31:45.000Z daily 0.9 https://cdn.brandfetch.io/FMS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Fresenius Medical Care Narrows 2026 Earnings Outlook Fresenius Medical Care narrowed its 2026 operating income outlook to a range from flat to a mid-single-digit percentage decline, versus its previous guidance of a mid-single-digit percentage change around the prior year’s level. The company cited operating results in the first nine months and expected fourth-quarter headwinds. It maintained its revenue outlook at approximately the prior year’s level. https://openbell.ai/news/VSURE:1793694698000 2026-11-03T08:31:38.000Z daily 0.9 https://cdn.brandfetch.io/VSURE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Verisure Reports Third Quarter 2026 Financial Results Verisure reported third-quarter 2026 revenue of 1,030.8 million, up 10.5% from 933.0 million in the prior period. Adjusted EBITDA increased to 488.6 million from 442.6 million, and Adjusted EBIT rose to 285.1 million from 250.3 million. Management said the company remains focused on prioritizing quality growth. https://openbell.ai/news/BOSS:1793694697000 2026-11-03T08:31:37.000Z daily 0.9 https://cdn.brandfetch.io/BOSS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Hugo Boss Issues Revenue Warning for 2026 Hugo Boss lowered its 2026 revenue outlook, now forecasting a high-single-digit percentage decline on a currency-adjusted basis, compared with its previous forecast of a mid-to-high-single-digit decline. The company also reported lower sales and profit in the preceding quarter. The revised guidance reflects a weaker outlook for the rest of the year. https://openbell.ai/news/BAYN:1793694697000 2026-11-03T08:31:37.000Z daily 0.9 https://cdn.brandfetch.io/BAYN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Bayer Reports Unexpected Q3 Earnings Growth Driven by Pharmaceuticals Bayer AG reported an unexpected increase in third-quarter operating results, driven by a recovery and strong growth in its Pharmaceuticals division. CEO Bill Anderson said the division had reached a turning point, and Bayer raised its full-year 2026 pharmaceutical margin expectations. Pharma’s performance helped offset ongoing market pressures in the agricultural and consumer-health divisions. https://openbell.ai/news/BIM:1793694697000 2026-11-03T08:31:37.000Z daily 0.9 https://cdn.brandfetch.io/BIM/w/400/h/400?c=1idopYfmtR7ZKg8QMud bioMérieux Reports Q3 2026 Revenue Exceeding Analyst Expectations bioMérieux reported Q3 2026 revenue of €1.04 billion, up 9.9% year over year on a reported basis and 8.1% organically, exceeding analyst expectations of €1.01 billion and 5.9% organic growth. The company confirmed its 2026 objectives of 3% to 5% organic revenue growth and contributive operating income that is stable or increases by up to 10% organically. https://openbell.ai/news/LECN:1793693057000 2026-11-03T08:04:17.000Z daily 0.9 https://cdn.brandfetch.io/LECN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Leclanché CEO States Need for 50 Million in Funding Leclanché SA’s CEO said the company needs to raise 50 million to fund ongoing operations and strategic progress. The report did not specify the currency, financing method, or any stock-market impact. https://openbell.ai/news/BIG:1793693026000 2026-11-03T08:03:46.000Z daily 0.9 https://cdn.brandfetch.io/BIG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Bigben Interactive Convenes Shareholders and Creditors for Accelerated Safeguard Plan Vote Bigben Interactive has begun the process of seeking shareholder and creditor votes on its accelerated safeguard plan after an August 17, 2026 judgment by the Commercial Court of Lille Métropole. The court is scheduled to rule on the plan’s adoption on December 9, 2026. If adopted, financial restructuring transactions are expected to be implemented and completed by the end of the first quarter of 2027; the company said it will provide further details on the timetable for capital transactions. https://openbell.ai/news/IMMNOV:1793693017000 2026-11-03T08:03:37.000Z daily 0.9 https://cdn.brandfetch.io/IMMNOV/w/400/h/400?c=1idopYfmtR7ZKg8QMud Immunovia AB Releases Q3 2026 Interim Report Immunovia reported Q3 2026 net sales of SEK 843,000 and an operating loss of SEK 17.7 million, down from SEK 25.1 million a year earlier. Operating cash flow improved to negative SEK 14.9 million from negative SEK 16.1 million, partly due to lower clinical-study spending. PancreaSure was being used at 36 surveillance centers, and the company submitted a Medicare coverage request on September 28. Immunovia also announced a rights issue of approximately SEK 63 million, about 80% of which was secured.